Black Friday saleUp to 70% OFF
CIPLA LTDCIPLA LTDCIPLA LTD

CIPLA LTD

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Options

CIPLA trade ideas

Cipla Forming a Darvas Box Cipla is the third-largest pharma company in India (IQVIA March 2021), the third-largest in the private pharma market of South Africa (IQVIA March 2021), and the largest Indian exporter to emerging markets and also amongst the most dispensed generic players in the US. Cipla has a presence in branded and unbranded generic market franchises, with leadership positions in India, South Africa, priority territories in Emerging markets, Europe, and the US, across major therapies and products categories. Pharma as a sector had shown some bullishness in the past week , IF the sector start performing Cipla can be considered, the sector has been in a bearish mode for the past couple of months trade only on your Due Diligence
NSE:CIPLALong
by nandagopan454
CIPLA -EW correction will be End soon..Hour chart for explaining more details in currently: Educational purpose only : CIPLA making 5 or 7 wave Correction . It's mean WXY or (WXYXZ )pattern. This correction happen in CIPLA higher degree wave (((3))) . Correction also within 0.382 Fibonacci levels.. ..this technical point gives confirm this is a wave (((4))) correction. Coming weeks CIPLA has complete wave Z or Retracement at 0.5 fib levels that's mean wave 2 formation. after market reach above 1000 point is CIPLA continue new rally ....for next 4 months...... Long Run takes minimum 20 day time .. Coming 10 days market will be parallel channel OR . If market break this channel takes long term holdings
NSE:CIPLALong
by jeevaramanan
Cipla Breakout1. Buy or Sell at your own risk 2. Don't risk more than 1%-2% of your capital as stop loss 3. Position Size formula:- Stop Loss/(Buy Price-Initial Stop Loss Price) 4. Either sell on initial stop loss hit or when closes below weekly supertrend After a TTM Sales and Profit growth of 11.5% and 15% respectively and after receiving an approval from the Subject Expert Committee (“SEC”) of the Central Drugs Standard Control Organization (“CDSCO”) to conduct local trials on anti Covid-19 pill Paxlovid, NSE:CIPLA has given a breakout with higher than average volume. The breakout came after a long consolidation since Jun'21. It's a buy with a stop loss at Rs.979.
NSE:CIPLALong
by akashbothra
CIPLA LONG About Cipla Cipla Ltd., incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 83,510.86 Crore) operating in Pharmaceuticals sector. Cipla Ltd. key Products/Revenue Segments include Pharmaceuticals, Other Operating Revenue, Export Incentives, Royalty Income and Scrap for the year ending 31-Mar-2021. For the quarter ended 31-12-2021, the company has reported a Consolidated Total Income of Rs 5,570.15 Crore, down .18 % from last quarter Total Income of Rs 5,580.47 Crore and up 5.98 % from last year same quarter Total Income of Rs 5,255.63 Crore. Company has reported net profit after tax of Rs 758.95 Crore in latest quarter. The company’s top management includes Dr.Y K Hamied, Ms.Punita Lal, Mr.Adil Zainulbhai, Dr.Peter Mugyenyi, Mr.Robert Stewart, Mr.P R Ramesh, Mr.Ashok Sinha, Mr.S Radhakrishnan, Mr.Umang Vohra, Ms.Samina Hamied, Mr.M K Hamied, Ms.Naina Lal Kidwai. Company has Walker Chandiok & Co. LLP as its auditors. As on 31-12-2021, the company has a total of 80.68 Crore shares outstanding.
NSE:CIPLALong
by Unknown_Learner
Cipla - Ready to Fly??Cipla seems ready to fly...Details on chart. I have been avoiding trade due to News driven market scenario. But 2 strong days is bringing some scripts back in Price action. But still one needs to be very very cautious because the uncertainty is not yet over. If cant avoid to trade then ensure to be stringent with SL. Capital protection is more important then earning in such conditions of market Caution: Im not SEBI registered analyst. Contact your financial advisor for more any decisions.
NSE:CIPLALong
by vishal1419